Skip to main content
SpringerLink
Log in

Ramipril: a novel long-acting angiotensin-converting enzyme inhibitor with the most suitable doses being 5 and 10mg

  • Newsletter Article
  • Published:
InPharma

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramipril: a novel long-acting angiotensin-converting enzyme inhibitor with the most suitable doses being 5 and 10mg. Inpharma Wkly. 536, 5 (1986). https://doi.org/10.1007/BF03307221

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03307221

Keywords

Search

Navigation